Evidence map›Paper›PMID 30250186›Full record

ArticleNature immunology2018

Infection perturbs Bach2- and Bach1-dependent erythroid lineage 'choice' to cause anemia.

Hiroki Kato, Ari Itoh-Nakadai, Mitsuyo Matsumoto, Yusho Ishii, Miki Watanabe-Matsui, Masatoshi Ikeda, Risa Ebina-Shibuya, Yuki Sato, Masahiro Kobayashi, Hironari Nishizawa and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Emergency myelopoiesis in solid cancers.British journal of haematology · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Heme as a differentiation-regulatory transcriptional cofactor.International journal of hematology · 2022
    Review
  17. Article
  18. Trained innate immunity, long-lasting epigenetic modulation, and skewed myelopoiesis by heme.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Hiroki KatoDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID http://orcid.org/0000-0002-4021-3356
Ari Itoh-NakadaiDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Mitsuyo MatsumotoDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yusho IshiiDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Miki Watanabe-MatsuiDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Masatoshi IkedaDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Risa Ebina-ShibuyaDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yuki SatoDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Masahiro KobayashiDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hironari NishizawaDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Katsushi SuzukiDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Akihiko MutoDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tohru FujiwaraDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yasuhito NannyaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Luca MalcovatiDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Mario CazzolaDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Seishi OgawaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hideo HarigaeDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kazuhiko IgarashiDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan. igarashi@med.tohoku.ac.jp.ORCID http://orcid.org/0000-0002-2470-2475
Tohoku University · JPKyoto University · JPUniversity of Pavia · ITShinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elucidation of how the differentiation of hematopoietic stem and progenitor cells (HSPCs) is reconfigured in response to the environment is critical for understanding the biology and disorder of hematopoiesis. Here we found that the transcription factors (TFs) Bach2 and Bach1 promoted erythropoiesis by regulating heme metabolism in committed erythroid cells to sustain erythroblast maturation and by reinforcing erythroid commitment at the erythro-myeloid bifurcation step. Bach TFs repressed expression of the gene encoding the transcription factor C/EBPβ, as well as that of its target genes encoding molecules important for myelopoiesis and inflammation; they achieved the latter by binding to their regulatory regions also bound by C/EBPβ. Lipopolysaccharide diminished the expression of Bach TFs in progenitor cells and promoted myeloid differentiation. Overexpression of Bach2 in HSPCs promoted erythroid development and inhibited myelopoiesis. Knockdown of BACH1 or BACH2 in human CD34

Indexed as

AnemiaAnimalsBasic-Leucine Zipper Transcription FactorsCell DifferentiationErythroid CellsErythropoiesisHumansInfectionsLipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutMyelodysplastic SyndromesBACH1 protein, humanBach1 protein, mouseBACH2 protein, humanBach2 protein, mouseBasic-Leucine Zipper Transcription FactorsLipopolysaccharides

Identifiers

PMID30250186
OpenAlexW2891065303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.